Table 1 Demographics and clinical variables in 232 patients admitted to medical floors at tertiary medical center with acute exacerbation of COPD; January 2013 – March 2016
BASELINE CHARACTERISTICS | Total (n = 232) | Pre-RVP (n = 99) | Post-RVP (n = 133) | p |
|---|---|---|---|---|
Age years; mean (SD) | 68.3 (11.6) | 68.1 (11.8) | 68.3 (11.5) | 0.8844 |
Females; n (%) | 122 (52.8) | 50 (50.9) | 72 (54.5) | 0.5427 |
BMI > 21; n (%) | 182 (78.4) | 74 (74.7) | 108 (81.2) | 0.2369 |
Smoking status | ||||
Current smokers; n (%) | 92 (39.7) | 44 (44.4) | 48 (36.1) | 0.1982 |
Ever smokers; n (%) | 203 (87.5) | 85 (85.9) | 118 (88.7) | 0.5143 |
Comorbidities | ||||
Obstructive Sleep Apnea; n (%) | 37 (15.9) | 12 (12.1) | 25 (18.8) | 0.1696 |
Hypertension; n (%) | 137 (59.1) | 51 (51.5) | 86 (64.7) | 0.0440 |
Diabetes Mellitus; n (%) | 65 (28.0) | 19 (19.2) | 46 (34.6) | 0.0098 |
Coronary Artery Disease; n (%) | 68 (29.3) | 21 (21.2) | 47 (35.3) | 0.0194 |
CHF; n (%) | 63 (27.2) | 23 (23.2) | 40 (30.1) | 0.2464 |
Atrial Fibrillation; n (%) | 29 (12.5) | 11 (11.1) | 18 (13.5) | 0.5810 |
CKD stage 2+; n (%) | 20 (8.6) | 11 (11.1) | 18 (13.5) | 0.5810 |
Chronic steroid dependence; n (%) | 26 (11.2) | 17 (17.2) | 9 (6.8) | 0.0130 |
Home oxygen use; n (%) | 93 (40.1) | 36 (36.4) | 57 (42.9) | 0.3182 |
Positive sputum Gram stain; n (%) | 50 (21.6) | 24 (24.2) | 26 (19.5) | 0.3898 |
NIV/HFNC use during admission; n (%) | 32 (13.8) | 16 (16.2) | 16 (12.0) | 0.3667 |
Medical Service at discharge; n (%) | ||||
Pulmonary | 84 (36.2) | 41 (41.4) | 43 (32.3) | 0.2694 |
Infectious Diseases | 19 (8.2) | 9 (9.1) | 10 (7.5) | |
Other | 129 (55.6) | 49 (49.5) | 80 (60.2) | |